NEW YORK (Reuters Health) - Many children and teens using insulin pumps to control type 1 diabetes experience skin problems at the infusion catheter insertion site, but few report thinking about ...

Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...

(Reuters Health) – - When diabetic patients report problems with their insulin pumps, the pump manufacturers collect that information – but there’s no easy way for researchers to analyze the data ...

The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them.

Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

All is not well in the land of insulin pumps -- the devices that deliver insulin to mostly Type 1 diabetics -- and the FDA wants to put a spotlight on the problem. Noting that there had been 18 ...

Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests. Insulin pump use is increasingly ...

The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses ...